chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a female patient who in 1968 when she was twelve months, she was vaccinated with MMR II and she almost died from the vaccine. She stopped breathing and had to be rushed to the hospital. She may have died if her dad was not holding her and noticed she had stopped breathing. The patient stated that she was immune to rubella. Stopped breathing was considered to be immediately life-threatening. Additional information has been requested.
PATIENT CAME TO THE PHARMACY WITH SWOLLEN LIPS AND  END UP HAVING ANAPHYLATIC REACTION AND BLOOD CLOT
6NOV95 stiff neck unchanged; no treatment; pt states was working @ health fair 29OCT95 outside in rain & wind feels neck strain & could be related to working not vax
Redness & swelling at vaccine administration sites (L) SQ 4cm swelling - thigh, (R) SQ 5cm swelling - thigh.
Hives 56 hours after administered on torso.  Disappeared 4 hours after Benadryl.  Hives again 80 hours after administration - again resolved with Benadryl.
Severe vertigo for first time ever starting on 1/4/2023  which was 8 1/2 weeks after vaccine.  Temporary disability as unable to move without being dizzy. Did Epley maneuver and have reduced severity but it has not gone completely away.  I do not know if this is related to vaccine but it was a sudden and new adverse experience after vaccine so thought I should report.
dizzy; Felt hot; acutely numb; This is a spontaneous report from a contactable other healthcare professional (patient). A 57-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 06Jan2021 13:45 at a single dose on left arm for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took cortisol [cortisone acetate]. The patient felt hot and acutely numb and dizzy within first few moments on 06Jan2021 13:45. The outcome of the events was recovered 06Jan2021 13:45. No treatment received for the adverse events. The reporter assessed as the events as non-serious. The patient was not pregnant at the time of vaccination. The facility where the most recent COVID-19 vaccine was administered was in the Public Health Clinic/Veterans Administration facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications received within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. Batch/lot was not available/provided to reporter at the time of report completion.  Information about lot/batch number has been requested.
CONFIRMED COVID-19 INFECTION; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805025 expiry: UNKNOWN) dose was not reported, administered on 14-MAR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. On 14-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 101 F. On 17-MAR-2021, the subject experienced confirmed covid-19 infection. Laboratory data included: COVID-19 PCR test (NR: not provided) POSITIVE. Treatment medications (dates unspecified) included: acetylsalicylic acid, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed covid-19 infection was not reported. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
the vial was initially stored in the refrigerator on 30-Jun-2022, the vial was administeed on 05-Aug-2022; No adverse event; used Moderna Covid-19 vaccine last week beyond its use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (used Moderna Covid-19 vaccine last week beyond its use by date), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 30-Jun-2022, the vial was administeed on 05-Aug-2022) and NO ADVERSE EVENT (No adverse event) in a 72-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B22A) for COVID-19 prophylaxis.     It was unknown the patient had any allergies to (medications, food and other products).  It was unknown patient ever had COVID + test or diagnosis. Medical history relating to mentioned adverse event and both Acute and Chronic illnesses at the time of vaccination was unknown. It was unknown recent change in status such as improvement or worsening. It was unknown other vaccines given within 1 month prior to Moderna COVID-19 vaccine (type, brand, lot, route, dose #).     On 05-Aug-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 05-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (used Moderna Covid-19 vaccine last week beyond its use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 30-Jun-2022, the vial was administeed on 05-Aug-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (used Moderna Covid-19 vaccine last week beyond its use by date), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 30-Jun-2022, the vial was administeed on 05-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (used Moderna Covid-19 vaccine last week beyond its use by date) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 30-Jun-2022, the vial was administeed on 05-Aug-2022).    No concomitant drug was reported. It was reported that vial did not undergo temperature excursions. The patient received second booster dose.  It was unknown adverse event cause patient to seek medical care (office visit, Urgent care, ER, hospitalized).  It was unknown the patient has experienced a similar event in the past. No treatment drug was reported.
Medical assistant accidentally administered an expired vaccine. Pt had no adverse reaction. Counseled MA on importance of checking dates prior to administration of vaccines. Made a general reminder on importance of checking vaccine 5 rights and expiration dates today at huddle.
swelling; pain at the injection site; it feels warm and it is "a little red"; it feels warm and it is "a little red"; This is a spontaneous report received from a contactable Other HCP. This 26-year-old female Other HCP reported for herself that she received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 13Feb2021 (at the age of 26-year-old) as 1st dose, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient received her first dose of the Pfizer COVID-19 vaccine on Saturday, 13Feb2021. The patient reported that, on an unspecified date she experienced pain at the injection site, swelling, and it feels warm and it was "a little red." The patient wanted to know that these side effects were common after receiving the Pfizer COVID-19 vaccine. The clinical outcome of the events was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
One day post vax, the pt developed a local reaction of redness and swelling. Further information is requested.
Severe fatigue, headache, body aches, and fever over the course of 48 hours.
Case previously recorded as MA2009-3332. Initial case report received from a physician via MedCom on 26 OCT 2009. A 2-year-old patient, was vaccinated with 0.5 ml S-OIV FLUVIRIN (batch no 100813-7P) i.m. on 24 OCT 2009. No adverse event was reported. Reference no. NA09-07008.
Stomach bug; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of GASTROENTERITIS (Stomach bug) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M820A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced GASTROENTERITIS (Stomach bug). At the time of the report, GASTROENTERITIS (Stomach bug) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications reported. no treatment details reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow-up received on 14-jul-2021,does not contain any new information.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
erythema, edema, tenderness, itching at injection site-post injection day 12 continues to worsen.  Pt questions if she should receive 2nd dose.
Patient developed erythema & puritis of left upper arm within hours of receiving injection there (10 inch X 10 inch area of erythema & slight induration.  Told to take BENADRYL as needed orally and use topical BENADRYL in affected area
Vomiting every 1 hour to 1 1/2 hours-started in the middle of the night. No fever and there was no swelling or redness at the sight. Behavior was fine, child playing-etc...
tightness was mixed with the pain; worst part of symptoms occurred around the larynx or trachea; worst part of symptoms occurred around the larynx or trachea; tightness was mixed with the pain; felt tight between the lower neck and upper chest area; felt tight between the lower neck and upper chest area; caused difficulty for me to breathe (inhale); caused difficulty for me to breathe (inhale), drink water, and swallow; This is a spontaneous report received from a contactable consumer (patient). A 33-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE- solution for injection; lot number- FA7485, expiry date not reported) via an unspecified route of administration into right arm, at the age of 33-year-old ,on 20Aug2021,16:30,at dose 2 single for covid-19 immunisation in a pharmacy or drug store. The patient's medical history includes allergic to soft-shell crab and giant river prawn. The patient didn't had any concomitant medications. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number EW0191, expiry date not reported) via an unspecified route of administration, at the right arm, on 29Jul2021,16:30 at age of 32-year-old at dose 1, single for covid-19 immunisation. The patient did not receive other vaccine in four weeks. The patient did not have prior COVID vaccination and was not tested post vaccination. On the night of Aug 21 22:00, he felt tight between the lower neck and upper chest area. It caused difficulty for him to breathe (inhale), drink water, and swallow. On the morning of Aug 22, those symptoms were more severe. The tightness was mixed with the pain. It was very hard to drink and swallow. During that moment, he noticed the worst part of symptoms occurred around the larynx or trachea. On Aug 23, 1:00 AM, the symptoms were getting better, but not fully normal. The patient did not receive treatment in response to the events. The outcome of the events was recovering at the time of report.  Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a registered nurse refers to a 12 years old female patient. The patient had a history of low grade fever approximately 1 week before receiving the vaccine. On an unspecified date, the patient was vaccinated intramuscularly with dose 1, 0.5 ml GARDASIL (Lot # not reported). No other co-suspects were reported. No concomitant medications were reported. The nurse reported that 2 weeks after receiving her first dose of GARDASIL, the patient developed a vaginal ulcer. The patient went to an unspecified ER, was seen and sent back to her primary physician. GARDASIL was discontinued. The outcome of vaginal ulcer was reported as recovered/resolved. No further information is available.
Started vomiting 2hours after receiving immuniztions.  Vomiting after feeding and sleeping more for 2 days and then was seen at local hospital emergency department.
It was called to my attention that the injection given to patient for his second Covid-19 vaccination dose was Pfizer and that it was determined after the injection that he should have received Moderna since his first dose was Moderna. The nurse DH who administered the injection said she monitored the recipient immediately following the injection for 15 minutes in the post observation area with no adverse effects reported before he left. I attempted to reach the recipient for follow up via phone and left multiple phone and text messages. Patient sent a text message reply that indicated "I am feeling fine. Tired and sore on Saturday, but back to normal on Sunday."  I followed up with a detailed voicemail advising him on the current CDC guidelines regarding receiving a mixed series of COVID vaccines including that no further dose is required at this time. I also advised him to inform his HCP and to report adverse events if he experiences any.
Discoloration approx 2 inches in diameter, some swelling, 2-3 small blisters, warm to touch, itching at site.
tingling; numbness starting from her left chest up to the sides of her left fingertips; rapid heart rate; pain in her left arm where she received the flu shot; experienced chest pain; headaches; flushing; chills; Initial information received on 26-Oct-2023 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp (Patient).  This case involves a 46 years old female patient who experienced tingling, numbness starting from her left chest up to the sides of her left fingertips, rapid heart rate, pain in her left arm where she received the flu shot, experienced chest pain, headaches, flushing and chills after receiving Influenza Quadrival A-B Vaccine [Fluzone Qiv].  The patient's past medical history, Concomitant medications, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Rubber sensitivity and Drug hypersensitivity.  On 02-Sep-2023, the patient received a unknown dose of suspect Influenza Quadrival A-B Vaccine Suspension for injection (Strength: standard, frequency: once, expiry date: 30-Jun-2024 and lot URV8200DA via intramuscular route in the left deltoid as immunization.  On 03-Sep-2023, the patient developed tingling (paraesthesia), numbness starting from her left chest up to the sides of her left fingertips (hypoaesthesia), rapid heart rate (heart rate increased), pain in her left arm where she received the flu shot (vaccination site pain), experienced chest pain (chest pain), headaches (headache), flushing and chills (latency: 1 day).  Action taken: not applicable.  The patient was treated with Diphenhydramine Hydrochloride (Benadryl [Diphenhydramine Hydrochloride]); And Prednisone for all events (Vaccination site pain, Paraesthesia, Hypoaesthesia, Chest pain, Headache, Flushing, Chills and Heart rate increased ).  At time of reporting, the outcome was Recovered / Resolved on an unknown date in 2023 for all events.
Fever, chills, diarrhea, headache , fatigue Now on 3rd day,
Patient started to experience warmth, pain and redness at injection site.  Also erythematous area measuring 7.5 cm X 6 cm.  Given CEPHALEXIN 500 mg TID X 7 days.
Client fainted approximately 5 min after vaccinations given. She reported feeling fine just after vaccines. During check out she fainted. Blood pressure 80/50 immediately following and within 10 minutes was 98/60. Mother advised client to be transported to ER for neuro inspection. Client reported pain on back of head.
Information has been received from a nurse practitioner concerning a 17 year old female without any drug reactions or allergies and with no pertinent medical history who on 01-DEC-2009 was vaccinated with the first dose of GARDASIL and then on 01-FEB-2010 was vaccinated with the second dose of GARDASIL. Concomitant therapy included birth control medication (name unspecified). On 02-FEB-2010 after receiving the second dose of GARDASIL, the patient broke out in hives, a macular papular rash that started on the back of her neck and went to the front of her body, the patient also experienced malaise and aches and pains. So the patient then called the nurse practitioner and told her the symptoms she was having and was told to take BENADRYL (manufacturer unspecified). The patient then went to the emergency room (ER) where they put her on MOTRIN (manufacturer unspecified) and hydroxyzine (manufacturer unspecified) and also ran blood work. At the ER, the ER physician asked the patient what might have caused this and the patient told the physician about getting GARDASIL. The ER physician then noticed that after receiving the first dose of GARDASIL on 01-DEC-2009 that she was in the ER with a much milder case of what she was experienced after the second dose of GARDASIL. The nurse practitioner reported that the patient followed up with her primary care office and OBGYN office and she was fine after reviewing blood work, but the patient did miss a day of school because of the experience. Additional information has been requested.
Patient received vaccine around 1300, patient called pharmacy at 1900 reporting "nerve-like pain in legs/feet". Patient has decided to monitor reaction and take OTC pain medication if necessary the day after. I documented conversation with patient in her profile and asked her to follow-up next day.
After having the vaccine, in December I did not have a menstrual cycle, I spotted for 1 or 2 days. In January I began bleeding very heavily and was going through a super tampon every 45 minutes. I began to get lightheaded and so my OB advised me to go to the ER. I went to the ER and they provided me with a medication to stop it called Medestrol acetate to stop the bleeding. They did a vaginal ultrasound but did not see anything abnormal. The medication did stop the bleeding and I followed up with my OB. Since January 25 to current, I have only gone for about 18 days without bleeding of some sort. I follow up with my OB in April to address these concerns.
Initial unsolicited case received from a health care professional (pharmacy intern) on 17 Aug 2017. This case involves a male patient (age not reported) who was vaccinated with a dose of FLUZONE (Batch number, expiry date, dose, dose in series, route, and site of administration were not reported) on 16 Aug 2017. The patient illness at the time of vaccination, pre-existing physician diagnosed allergies, birth defects, medical conditions were reported as unknown, and any other vaccinations within 4 weeks of vaccinations was unknown. Concomitant medications were not reported. On 17 Aug 2017, one day after the vaccination, the patient developed nausea, vomiting and general flu like symptoms. The patient required to seen in ER (emergency room) / doctor visit (also reported as the reporter advise her that if the symptoms are concerning they should see their primary provider.) No relevant laboratory examination were performed. Corrective treatment was not reported. The outcome of all the events were reported as not recovered. List of documents held by sender: none.
1 day p/vax pt exp GI upset, diarrhea, fever, swollen glands in neck & pruritic rash x 2 days;
COVID-19 Vaccine EUA. I am currently experiencing redness the size of a silver dollar on and around the area of where my injection was. Also I am experiencing heat coming off the red area and itchiness. Also there are times where my forearm feels as though the blood flow is being constrained. This has been happening already for over 8 days and am concerned because it is not going away.
Syncope, weakness, cold clammy 69/36, HR 58, 115/80, 120/80, O2Sat 100%
There were no adverse events. The patient wasn't in the approved age group for Moderna booster.
Moderate to severe injection site pain  starting 12 hours after vaccine resolved after being present another 12 hours
Patient states lump at injection site that is itchy and warm. She says it started right after receiving the vaccine and is about 3 inches in diameter.
Patient in for WCC on 7-19-02 and given MMR and Varicella. At time of visit pt. had been on Amoxil for 3 days.Patient was seen on 7/25 for rash termed as non-specific at that time from the physician. Mom returned with the child on 7/31 because of worsening of the rash described as erhthemia papules/ blanching, non -puretic at the time involving the face, hands, arms, legs, back and abd..Mom returned on 8-1-02 with same described rash only involving most all of body.
Pt developed fever poor appetite sweats at 8:30 PM 10/31/13. Temp up to 101.4 pt restless uncomfortable all night, Mom gave Tylenol. Temp 100.7 at 4:30 AM 11/1/13. Temp 99.6 in office today at 2:00,  Wheezing on exam, no rash, oral air way good, rest of exam normal.
Can't hear with my left ear; Lost my tastebuds; This spontaneous case was reported by a consumer and describes the occurrence of DEAFNESS (Can't hear with my left ear) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DEAFNESS (Can't hear with my left ear) (seriousness criterion medically significant) and AGEUSIA (Lost my tastebuds). At the time of the report, DEAFNESS (Can't hear with my left ear) and AGEUSIA (Lost my tastebuds) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. further information has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. further information has been requested.
CHRONIC HYPOXEMIC RESPIRATORY FAILURE 6/25/2022 &  12/23/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
1 week after shot lupus like reaction with myalgias, SOB, CP, pleuritic CP, headaches.
Yellow fever vaccine 9/24/2005 lethargy/malaise/fever. Possible B 4 No Support treatment; pt admitted to hospital. Pt had received the yellow fever vaccine 2 - 3 weeks prior to admission with above symptoms.